A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease

Clinical trial NCT06610526 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06610526
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2024-08-23
Primary completion: 2027-05-31
Enrollment: 731

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.